Sulfuric Acid

Sulfuric Acid

SCHEMBL3390874

O=NOS(=O)(=O)O.O=S(=O)(O)O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
CA2 P00918 1/20 0.39
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
BLM P54132 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28950 0.97
SCHEMBL27541517 0.93
SCHEMBL28188291 0.93
SCHEMBL199343 0.93
SCHEMBL9438163 0.93
Ammonia Solution, Strong SCHEMBL6544918 0.93
SCHEMBL9113124 0.93
SCHEMBL9309058 0.93
Hydrochloric Acid SCHEMBL28213776 0.90
SCHEMBL28006682 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0701989-B1 Process for preparing mono- and dicarboxylic acids from unsaturated fatty acids and/or their derivatives NOVANCE S A (FR) 1998-10-28 EP claimed
US-20240182302-A1 PROCESS FOR RECYCLING NITROGEN OXIDES FROM NITROSYL SULFURIC ACID TO PRODUCE CONCENTRATED OR HIGHLY CONCENTRATED NITRIC ACID AND SULFURIC ACID PLINKE GMBH (DE) 2024-06-06 US disclosed
EP-4313856-A1 PROCESS FOR RECYCLING NITROGEN OXIDES FROM NITROSYL SULFURIC ACID TO PRODUCE CONCENTRATED OR HIGHLY CONCENTRATED NITRIC ACID AND SULFURIC ACID PLINKE GmbH (DE) 2024-02-07 EP disclosed
WO-2023181907-A1 COMPOUND, COMPOSITION FOR FORMING ANISOTROPIC DYE FILM, ANISOTROPIC DYE FILM, AND OPTICAL ELEMENT 三菱ケミカル株式会社 2023-09-28 WO disclosed
CN-116143081-A Method for removing nitrogen oxides contained in concentrated sulfuric acid 昆明理工大学 2023-05-23 CN disclosed
CN-105218396-B A kind of preparation method of azo-compound 上海安诺其集团股份有限公司 2017-11-03 CN disclosed
CN-105254517-B A kind of naphthalene cycle compound and preparation method thereof 上海安诺其集团股份有限公司 2017-08-25 CN disclosed
CN-105152964-B Azo-compound 上海安诺其集团股份有限公司 2017-03-22 CN disclosed
CN-105367443-A Continuous production process and device of diazo compound ZHEJIANG DIBANG CHEMICAL CO LTD 2016-03-02 CN disclosed
EP-2691087-A2 PHARMACEUTICAL COMPOSITION CONTAINING NO, PROCESS FOR THE PREPARATION AND USE THEREOF Szabó László Gábor (HU) 2014-02-05 EP disclosed
CN-1284775-C Process for producing 3-unsubstituted-5-amino-4-nitrosopyrazole compound, 2-hydroxyimino-3-oxopropanenitrile, 3-hydrazono-2-hydroxyimino propanenitrile compound, and process for producing these compounds UBE INDUSTRIES (JP) 2006-11-15 CN disclosed
CN-1620436-A Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these UBE INDUSTRIES (JP) 2005-05-25 CN disclosed
US-20050096472-A1 Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these UBE INDUSTRIES, LTD. (JP) 2005-05-05 US disclosed
EP-1475369-A1 PROCESS FOR PRODUCING 3-UNSUBSTITUTED 5-AMINO-4-NITROSOPYRAZOLE COMPOUND, AND 2-HYDROXYIMINO-3-OXOPROPIONITRILE, 3-HYDRAZONO-2-HYDROXYIMINOPROPIONITRILE COMPOUND, AND PROCESSES FOR PRODUCING THESE Ube Industries, Ltd. (JP) 2004-11-10 EP disclosed
EP-0937703-B1 METHOD FOR PURIFYING PYRUVIC ACID COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2003-05-21 EP disclosed
US-6348617-B1 REACTING PYRUVIC ACID COMPOUND IN WATER WITH AMMONIUM OR ALKALI METAL BISULFITE TO GIVE AQUEOUS SOLUTION OF BISULFITE ADDUCT, ISOLATING BY PHASE SEPARATION, OPTIONALLY USING HYDROPHOBIC SOLVENT, CONTACTING WITH ACID TO DECOMPOSE ADDUCT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-02-19 US disclosed
CN-1261308-A Optical recording medium and method for manufacturing the same MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) 2000-07-26 CN disclosed
EP-0937703-A1 METHOD FOR PURIFYING PYRUVIC ACID COMPOUNDS SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1999-08-25 EP disclosed
US-5104991-A PREPARATION OF PHENYLOXADIAZOLYLANILINES BASF AKTIENGESELLSCHAFT (DE) 1992-04-14 US disclosed
US-4486610-A AROMATIC OR HALOGENATED HYDROCARBON CIBA-GEIGY CORPORATION (US) 1984-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050096472-A1 Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these CYP1A1, CYP2E1, NOS3 CA5A 1120/4885CA5B 1430/4885CA2 3005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.